Filing Flows

Filing Flows › Viridian Therapeutics (VRDN) › Who owns the stock

Who owns Viridian Therapeutics (VRDN) stock

202 funds reported Viridian Therapeutics (VRDN) shares in their latest 13F filings, worth $2.6B in all. The largest holder is FMR LLC ($305M). Last quarter 126 funds added to their stakes and 104 cut them.

Largest holders of VRDN (13F)Largest holders of VRDN (13F)FMR LLC$305MVanguard Group$175MBlackRock$157MBellevue Group AG$124MParadigm Biocapital Advisors LP$124MKynam Capital Management, LP$119MState Street$113MPrice T Rowe Associates$106MFairmount Funds Management LLC$93.5MVanguard Capital Management LLC$84.1M

Largest holders (13F)

FundSharesValueChangeQuarter
FMR LLC16,604,740$305Mincrease2026-06-30
Vanguard Group5,612,144$175Mincrease2025-12-31
BlackRock8,551,488$157Mincrease2026-06-30
Bellevue Group AG6,731,909$124Mincrease2026-06-30
Paradigm Biocapital Advisors LP6,723,788$124Mincrease2026-06-30
Kynam Capital Management, LP6,453,877$119Mincrease2026-06-30
State Street6,124,976$113Mincrease2026-06-30
Price T Rowe Associates5,748,410$106Mincrease2026-06-30
Fairmount Funds Management LLC5,090,928$93.5Mincrease2026-06-30
Vanguard Capital Management LLC4,576,860$84.1Mincrease2026-06-30
Deep Track Capital, LP3,592,740$66.0Mincrease2026-06-30
VR Adviser, LLC3,257,917$59.8Mdecrease2026-06-30
Wellington Management Group LLP3,128,362$57.5Mincrease2026-06-30
Vanguard Portfolio Management LLC2,752,827$50.6Mincrease2026-06-30
Geode Capital Management, LLC2,501,869$46.0Mincrease2026-06-30

Viridian Therapeutics' latest quarter

Viridian Therapeutics, Q3 2026: revenue $25.8M (-64% year over year), operating margin -401.8%, net loss $101M, operating cash flow −$92.8M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most VRDN stock?

By the latest 13F filings: FMR LLC ($305M); Vanguard Group ($175M); BlackRock ($157M); Bellevue Group AG ($124M); Paradigm Biocapital Advisors LP ($124M).

What is the short interest in VRDN?

18,002,311 shares were sold short at the 2026-10-15 settlement, 0.2% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.